In Vivo Vascularization of Endothelial Cells Derived from Bone Marrow Mesenchymal Stem Cells in SCID Mouse Model

Document Type : Correction


1 Department of Clinical Biochemistry, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran

2 Department of Biochemistry, School of Medical Sciences, Iran University of Medical Sciences, Tehran, Iran


In this article published in Cell J, Vol 18, No 2, Jul-Sep (Summer) 2016, on pages 179-188, the authors found that
Figure 2A was the same as the one that has already been published and it was confusing. The following figure’s legend
is corrected in reference 9.
The authors would like to apologies for any inconvenience caused.



    1. Jackson KA, Majka SM, Wang H, Pocius J, Hartley CJ, Majesky MW, et al. Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J Clin Invest. 2001; 107(11): 1395-1402.
    2. Xu J, Liu X, Jiang Y, Chu L, Hao H, Liua Z, et al. MAPK/ERK signalling mediates VEGF-induced bone marrow stem cell differentiation into endothelial cell. J Cell Mol Med. 2008; 12(6A): 2395-2406.
    3. Wu KH, Zhou B, Lu SH, Feng B, Yang SG, Du WT, et al. In vitro and in vivo differentiation of human umbilical cord derived stem cells into endothelial cells. J Cell Biochem. 2007; 100(3): 608-616.
    4. Oswald J, Boxberger S, Jørgensen B, Feldmann S, Ehninger G, Bornhäuser M, et al. Mesenchymal stem cells can be differentiated into endothelial cells in vitro. Stem Cells. 2004; 22(3): 377-384.
    5. Nourse MB, Halpin DE, Scatena M, Mortisen DJ, Tulloch NL, Hauch KD, et al. VEGF induces differentiation of func­tional endothelium from human embryonic stem cells: im­plications for tissue engineering. Arterioscler Thromb Vasc Biol. 2010; 30(1): 80-89.
    6. Cao Y, Sun Z, Liao L, Meng Y, Han Q, Zhao RC. Human adipose tissue-derived stem cells differentiate into en­dothelial cells in vitro and improve postnatal neovascu­larization in vivo. Biochem Biophys Res Commun. 2005; 332(2): 370-379.
    7. Huang YL, Qiu RF, Mai WY, Kuang J, Cai XY, Dong YG, et al. Effects of insulin-like growth factor-1 on the properties of mesenchymal stem cells in vitro. J Zhejiang Univ Sci B. 2012; 13(1): 20-28.
    8. Jazayeri M, Allameh A, Soleimani M, Jazayeri SH, Ka­zemnejad S. Capillary network formation by endothelial cells differentiated from human bone marrow mesenchy­mal stem cells. Iran J Biotech. 2008; 6(1): 29-35.
    9. Jazayeri M, Allameh A, Soleimani M, Jazayeri SH, Piryaei A, Kazemnejad S. Molecular and ultrastructural characterization of endothelial cells differentiated from human bone marrow mesenchymal stem cells. Cell Biol Int. 2008; 32(10): 1183-1192.
    10. Jiang Y, Jahagirdar BN, Reinhardt RL, Schwartz RE, Keene CD, Ortiz-Gonzalez XR, et al. Pluripotency of mes­enchymal stem cells derived from adult marrow. Nature. 2002; 418(6893): 41-49.
    11. Kane NM, Xiao Q, Baker AH, Luo Z, Xu Q, Emanueli C. Pluripotent stem cell differentiation into vascular cells: a novel technology with promises for vascular re (genera­tion). Pharmacol Ther. 2011; 129(1): 29-49.
    12. Vittet D, Prandini MH, Berthier R, Schweitzer A, Martin-Sisteron H, Uzan G, et al. Embryonic stem cells differenti­ate in vitro to endothelial cells through successive matura­tion steps. Blood. 1996; 88(9): 3424-3431.
    13. Kaneko Y, Tajiri N, Shinozuka K, Glover LE, Weinbren NL, Cortes L, et al. Cell therapy for stroke: Emphasis on opti­mizing safety and efficacy profile of endothelial progenitor cells. Curr Pharm Des. 2012; 18(25): 3731-3734.
    14. Melly L, Boccardo S, Eckstein F, Banfi A, Marsano A. Cell and gene therapy approaches for cardiac vascularization. Cells. 2012; 1(4): 961-975.
    15. Silva GV, Litovsky S, Assad JA, Sousa AL, Martin BJ, Vela D, et al. Mesenchymal stem cells differentiate into an endothelial phenotype, enhance vascular density, and im‌prove heart function in a canine chronic ischemia model. Circulation. 2005; 111(2): 150-156.
    16. Tsukada S, Kwon SM, Matsuda T, Jung SY, Lee JH, Lee SH, et al. Identification of mouse colony-forming endothe‌lial progenitor cells for postnatal neovascularization: a novel insight highlighted by new mouse colony-forming assay. Stem Cell Res Ther. 2013; 4(1): 20.
    17. Kalka C, Masuda H, Takahashi T, Kalka-Moll WM, Silver M, Kearney M, et al. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovasculari‌zation. Proc Natl Acad Sci USA. 2000; 97(7): 3422-3427.
    18. Kawamoto A, Gwon HC, Iwaguro H, Yamaguchi JI, Uchi‌da S, Masuda H, et al. Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial is‌chemia. Circulation. 2001; 103(5): 634-637.
    19. Griese DP, Ehsan A, Melo LG, Kong D, Zhang L, Mann MJ, et al. Isolation and transplantation of autologous cir‌culating endothelial cells into denuded vessels and pros‌thetic grafts implications for cell-based vascular therapy. Circulation. 2003; 108(21): 2710-2715.
    20. Nagaya N, Fujii T, Iwase T, Ohgushi H, Itoh T, Uematsu M, et al. Intravenous administration of mesenchymal stem cells improves cardiac function in rats with acute myocar‌dial infarction through angiogenesis and myogenesis. Am J Physiol Heart Circ Physiol. 2004; 287(6): H2670-2676.
    21. Wei L, Fraser JL, Lu ZY, Hu X, Yu SP. Transplantation of hypoxia preconditioned bone marrow mesenchymal stem cells enhances angiogenesis and neurogenesis after cer‌ebral ischemia in rats. Neurobiol Dis. 2012; 46(3): 635- 645.
    22. Carmeliet P. Angiogenesis in health and disease. Nat Med. 2003; 9(6): 653-660.
    23. Polverini PJ. Angiogenesis in health and disease: insights into basic mechanisms and therapeutic opportunities. J Dent Educ. 2002; 66(8): 962-975.
    24. Carmeliet P. Angiogenesis in life, disease and medicine. Nature. 2005; 438(7070): 932-936.
    25. Tímár J, Döme B, Fazekas K, Janovics A, Paku S. Angi‌ogenesis-dependent diseases and angiogenesis therapy. Pathol Oncol Res. 2001; 7(2): 85-94.
    26. Carmeliet P, Jain RK. Molecular mechanisms and clinical applications of angiogenesis. Nature. 2011; 473(7347): 298-307.